Prevalence of selected sexually transmitted infectious agents in a cohort of asymptomatic soldiers in Austria - Parasites & Vectors - Parasites & Vectors
Rowley J, Vander Hoorn SV, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2006. Bull World Health Organ. 2016;97:548–62.
Korzeniewski K. Sexually transmitted infections among army personnel in the military environment. Sex Trans Infect. 2012;71:165–82.
Gaydos JC, McKee KT, Faix DJ. Sexually transmitted infections in the military: new challenges for an old problem. Sex Transm Infect. 2015;91:536–7.
Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?—A position statement from the European STI Guidelines Editorial Board. JEADV. 2018;32:1845–51.
Mielczarek E, Blaszkowska J. Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure. Infection. 2016;44:447–58.
Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997;24:353–60.
Fichorova RN. Impact of Trichomonas vaginalis on innate immune responses and reproductive outcome. J Reprod Immunol. 2009;83:185–9.
Tao L, Han L, Li X, Gao Q, Pan L, Wu L, et al. Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. BMC Public Health. 2014;14:1185.
Ghosh I, Muwonge R, Mittal S, Banerjee D, Kundu P, Mandal R, et al. Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions. J Clin Virol. 2017;87:43–8.
Mercer F, Johnson PJ. Trichomonas vaginalis: pathogenesis, symbiont interactions, and host cell immune response. Trends Parasitol. 2018;34:683–93.
Sutcliffe S, Giovannucci E, Alderete JF, Chang TE, Gaydos CA, Zenilman JM, et al. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2015;15:939–45.
Weisburg WG, Tully JG, Rose DL, Petzel JP, Oyaizu H, Yang D, et al. A phylogenetic analysis of the mycoplasmas: basis for their classification. J Bacteriol. 1989;171:6455–67.
Fichorova R, Fraga J, Rappelli P, Fiori PL. Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma. Research Microbiol. 2017. https://doi.org/10.1016/j.resmic.2017.03.005.
Cao CJ, Wang YF, Fang DM, Hu Y. Relation between mycoplasma infection and recurrent spontaneous abortion. Eur Rev Med Pharmacol Sci. 2018;22:2207–11.
Ahmadi MH, Mirsalehian A, Gilani MAS, Bahador A, Talebi M. Asymptomatic infection with Mycoplasma hominis negatively affects semen parameters and leads to male infertility as confirmed by improved semen parameters after Antibiotic treatment. Urology. 2017;100:97–102.
Zeighami H, Peerayesh SN, Yazdi RS, Sorouri R. Prevalence of Ureaplasma urealyticum and Ureaplasma parvum in semen of infertile and healthy men. Int J STD AIDS. 2009;20:387–90.
Gupta V, Dhawan B, Khanna N, Agarwal N, Bhattacharya SN, Sreenivas V, et al. Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infections. Diagn Microbiol Infect Dis. 2008;60:95–7.
Humburg J, Frei R, Wight E, Troeger C. Accuracy of urethral swab and urine analysis for the detection of Mycoplasma hominis and Ureaplasma urealyticum in women with lower urinary tract symptoms. Arch Gynecol Obstet. 2012;285:1049–53.
Horner PJ, Martin DH. Mycoplasma genitalium infection in men. J Infect Dis. 2017;216:396–405.
STI Treatment Guidelines, 2021. https://www.cdc.gov/std/treatment-guidelines/default.htm. Accessed on 10.10.2022.
Fettweiss JM, Serrano MG, Huang B, Brooks JP, Glascock AL, Sheth NU, et al. An emerging Mycoplasma associated with trichomoniasis, vaginal infection and disease. PLoS ONE. 2014;9:e110943.
CDC. Sexually Transmitted Disease Surveillance 2012. Atlanta: U.S. Department of Health and Human Science, 2013. http://www.cdc.gov/sTD/stats12/Surv2012.pdf. Accessed on 10.10.2022.
Malhotra M, Sood S, Mukherjee A, Muralidhar S, Bala M. Genital Chlamydia trachomatis: an update. Indian J Med Res. 2013;138:303–16.
Marrazzo JM, Whittington WL, Celum CL, Handsfield HH, Clark A, Cles L, et al. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis. 2001;28:219–25.
Todd CS, Haase C, Stoner B. Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health. 2001;91:461–4.
Garnett GP, Bowden JF. Epidemiology and control of curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis. 2000;27:588–99.
Kengne P, Veas F, Vidal N, Rey JL, Cuny G. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol. 1994;40:819–31.
Van Kuppeveld FJM, Van Der Logt JTM, Angulo AF, Van Zoest MJ, Quint GV, Niesters GM, et al. Genus- and species-specific identification of mycoplasma by 16S rRNA amplification. Appl Environ Microbiol. 1992;58:2606–15.
Jensen JS, Uldum SA, Søndergård-Andersen J, Vuust J, Lind K. Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. J Clin Microbiol. 1991;29:46–50.
Safarkar R, Mehrabadi JF, Noormohammadi Z, Mirnejad R. Development a rapid and accurate multiplex real time PCR method for the detection Chlamydia trachomatis and Mycoplasma hominis. J Clin Lab Anal. 2017;31:e22126.
Hsu MC, Tsai PY, Chen KT, Li LH, Chiang CC, Tsai JJ, et al. Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan. J Med Microbiol. 2006;55:301–8.
Korzeniewski K, Juszczak D, Paul P. Sexually transmitted infections in the military environment. Int Marit Health. 2020;71:207–12.
Pellrud H, Golparian D, Nilsson CS, Falk M, Fredlund H, Unemo M. Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden. Acta Derm Venereol. 2015;95:343–4.
Hilmarsdottir I, Sigmundsdottir E, Eiriksdottir A, Golparian D, Unemo M. Trichomonas vaginalis is rare among women in Iceland. Acta Derm Venereol. 2017;97:1258–60.
Chiu SF, Huang PJ, Cheng WH, Huang CY, Chu LJ, Lee CC, et al. Vaginal microbiota of the sexually transmitted infections caused by Chlamydia trachomatis and Trichomonas vaginalis in women with vaginitis in Taiwan. Microorganisms. 2021;9:1864. https://doi.org/10.3390/microorganisms9091864.
Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44:13–22.
Joo CY, Choi DW. Prevalence of Trichomonas vaginalis in Korean military Personnel. Kisaengchunghak Chapchi. 1980;18:247–52.
McKee KT Jr, Jenkins PR, Garner R, Jenkins RA, Nannis ED, Hoffman IF, et al. Features of urethritis in a cohort of male soldiers. Clin Infect Dis. 2000;30:736–41.
Christofolini DM, Leuzzi L, Mafra FA, Rodart I, Kayaki EA, Bianco B, et al. Prevalence of cases of Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Chlamydia trachomatis in women with no gynecologic complaints. Reprod Med Biol. 2012;11:201–5.
Bautista CT, Wurapa EK, Sateren WB, Hollingsworth BP, Sanchez JL. Longitudinal association of gonorrhea and bacterial vaginosis with repeat chlamydia diagnoses among U.S. Army women: a retrospective cohort analysis. Mil Med Res. 2018;5:37.
Van Der Pol B. Clinical and laboratory testing for Trichomonas vaginalis infection. J Clin Microbiol. 2016;54:7–12.
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015;64:1–137.
Donders GG, Vieira-Baptista P. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women. Diagn Cytopathol. 2017;45:472–3.
Cox C, Saxena N, Watt AP, Gannon C, McKenna JP, Fairley DJ, et al. The common vaginal commensal bacterium Ureaplasma parvum is associated with chorioamnionitis in extreme preterm labor. J Matern Fetal Neonatal Med. 2016;29:3646–51.
Taylor-Robinson D, Lamont RF. Mycoplasmas in pregnancy. BJOG. 2011;118:164–74.
Safari M, Bakhshi A, Erami M, Kheirkhah B, Pourbakhsh A, Pourbabei H. Sequences of Mycoplasma hominis in patients with urinary tract infection in a hospital in Kashan, Iran. Res J Microbiol. 2015;10:260–9.
Lee MY, Kim MH, Lee WI, Kang SY, La JY. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis. 2010;57:90–5.
Choi JB, Lee SJ, Lee MK, Lee SJ, Park DC, Kim HY, et al. Prevalence and antimicrobial susceptibility of Ureaplasma spp. and Mycoplasma hominis in asymptomatic individuals in Korea. Microb Drug Resist. 2018;24:1391–6.
Chandeying V, Skov S, Duramad P, Makepeace B, Ward M, Khunigij P. The prevalence of urethral infections amongst asymptomatic young men in Hat Yai, southern Thailand. Int J STD AIDS. 2000;11:402–5.
Gupta V, Dhawan B, Khanna N, Agarwal N, Bhattacharya SN, Sreenivas V, et al. Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infection. Diagn Microbiol Infect Dis. 2008;60:95–7.
Kasprzykowska U, Sobieszczanska B, Duda-Madej A, Secewicz A, Nowicka J, Gosciniak G. A twelve-year retrospective analysis of prevalence and antimicrobial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of lower Silesia in Poland. Eur J Obstet Gynecol Reprod Biol. 2018;220:44–9.
Hata A, Honda Y, Asada K, Sasaki Y, Kenri T, Hata D. Mycoplasma hominis meningitis in a neonate: case report and review. J Infect. 2008;57:338–43.
Saadat S, Karami P, Jafari M, Kholoujini M, Rikhtegaran Tehrani Z, Mohammadi Y, et al. The silent presence of Mycoplasma hominis in patients with prostate cancer. Pathog Dis. 2020;78:ftaa037. https://doi.org/10.1093/femspd/ftaa037.
Al-Sweih NA, Al-Fadli AH, Omu AE, Rotimi VO. Prevalence of Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections and seminal quality in infertile and fertile men in Kuwait. J Androl. 2012;33:1323–9.
Arya OP, Tong CY, Hart CA, Pratt BC, Hughes S, Roberts P, et al. Is mycoplasma hominis a vaginal pathogen? Sex Transm Infect. 2001;77:58–62.
Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?—a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018;32:1845–51.
Gdoura R, Kchaou W, Chaari C, Znazen A, Keskes L, Rebai T, et al. Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men. BMC Inf Dis. 2007;7:129. https://doi.org/10.1186/1471-2334-7-129.
Martin DH, Zozaya M, Lillis RA, Myers L, Nsuami MJ, Ferris MJ. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis. 2013;207:1922–31.
Allen-Daniels MJ, Serrano MG, Pflugner LP, Fettweis JM, Prestosa MA, Koparde VN, et al. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. Am J Obstet Gynecol. 2015;212:e1-79.e13.
Morency P, Dubois MJ, Gresenguet G. Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Inf. 2001;77:125–9.
Andersen B, Sokolowski A, Østergaard L, Kjłlseth Młller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2007;83:237–41.
Baumann L, Cina M, Egli-Gany D, Goutaki M, Halbeisen FS, Lohrer GR, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect. 2018;94:255–62.
Gottesman T, Yossepowitch O, Samra Z, Rosenberg S, Dan M. Prevalence of Mycoplasma genitalium in men with urethritis and in high risk asymptomatic males in Tel Aviv: a prospective study. Int J STD AIDS. 2017;28:127–32.
Tjagur S, Mandar R, Punab M. Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia. Infect Dis. 2018;50:133–9.
Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, et al. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clin Microbiol Infect. 2018;24:533–9.
Braam JF, Van Dam AP, Bruisten SM, Van Rooijen MS, de Vries HJC, Schim van der Loeff MF, et al. Macrolide-resistant Mycoplasma genitalium impairs clinical improvement of male urethritis after empirical treatment. Sex Transm Dis. 2021. https://doi.org/10.1097/OLQ.0000000000001591.
Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev. 2011;24:498–514.
Andersen B, Sokolowski I, Ostergaard L, Kjolseth Moller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2007;83:237–41.
Gdoura V, Daoudi F, Bouzid F, Ben Salah F, Chaigneau C, Sueur JM, et al. Detection of Chlamydia trachomatis in semen and urethral specimens from male members of infertile couples in Tunisia. Eur J Contracept Reprod Health Care. 2001;6:14–20.
Kim HJ, Park JK, Park S, Kim YG, Choi H, Ko JI, et al. The prevalence of causative organisms of community-acquired urethritis in an age group at high risk for sexually transmitted infections in Korean Soldiers. J R Army Med Corps. 2017;163:20–2.
Duron S, Panjo H, Bohet A, Bigaillon C, Sicard S, Bajos N, et al. Prevalence and risk factors of sexually transmitted infections among French service members. Plos ONE. 2018;13:e0195158.
Trei JS, Canas LC, Gould PL. Reproductive tract complications associated with Chlamydia trachomatis infection in US Air Force males within 4 years of testing. Sex Trans Dis. 2008;35:827–33.
Lesiak-Markowicz I, Schötta A, Stockinger H, Stanek G, Markowicz M. Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014–2017 from Austrian patients. Sci Rep. 2019;4:18327.
European Center for Disease Prevention and Control. Sexually transmitted infections in Europe 2013. Stockholm: ECDC, 2015. htpp://ecdc.europa.eu/en/publications/Publications/sexual-transmitted-infections europe-surveillance-report-2013.pd. Accessed on 10.10.2022.
Comments
Post a Comment